{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:00:50Z","timestamp":1783677650719,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"crossref","award":["JGG"],"award-info":[{"award-number":["JGG"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The causes for thousands of individually rare recessive diseases have been discovered since the adoption of next generation sequencing (NGS). Following the molecular diagnosis in older children in a family, parents could use this information to opt for fetal genotyping in subsequent pregnancies, which could inform decisions about elective termination of pregnancy. The use of NGS diagnostic sequencing in families has not been demonstrated to yield benefit in subsequent pregnancies to reduce recurrence. Here we evaluated whether genetic diagnosis in older children in families supports reduction in recurrence of recessive neurogenetic disease.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Retrospective study involving families with a child with a recessive pediatric brain disease (rPBD) that underwent NGS-based molecular diagnosis. Prenatal molecular testing was offered to couples in which a molecular diagnosis was made, to help couples seeking to prevent recurrence. With this information, families made decisions about elective termination. Pregnancies that were carried to term were assessed for the health of child and mother, and compared with historic recurrence risk of recessive disease.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Between 2010 and 2016, 1172 families presented with a child a likely\u00a0rPBD, 526 families received a molecular diagnosis, 91 families returned to the clinic with 101 subsequent pregnancies, and 84 opted for fetal genotyping. Sixty tested negative for recurrence for the biallelic mutation\u00a0in the fetus, and all, except for one spontaneous abortion, carried to term, and were unaffected at follow-up. Of 24 that genotyped positive\u00a0for\u00a0the biallelic mutation, 16 were electively terminated, and 8 were carried to term and showed features of disease similar to that of the older\u00a0affected sibling(s). Among the 101 pregnancies, disease recurrence in living offspring deviated from the expected 25% to the observed 12% ([95% CI 0\u00b704 to 0\u00b720], <jats:italic>p<\/jats:italic>\u2009=\u20090\u00b7011).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Molecular diagnosis in an older child, coupled with prenatal fetal genotyping in subsequent pregnancies and genetic counselling, allows families to make informed decisions to reduce recessive neurogenetic disease recurrence.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12920-020-0714-1","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T09:19:35Z","timestamp":1589361575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular diagnosis in recessive pediatric neurogenetic disease can help reduce disease recurrence in families"],"prefix":"10.1186","volume":"13","author":[{"given":"Mahmoud Y.","family":"Issa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinayida","family":"Chechlacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee D.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McEvoy-Venneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denice","family":"Belandres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnaa M.","family":"Elbendary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled R.","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Nabil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha S.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-9220","authenticated-orcid":false,"given":"Joseph G.","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"714_CR1","unstructured":"Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: final data for 2015. Natl Vital Stat Rep. 2017;66:1\u201375."},{"key":"714_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0025-6196(11)63220-5","volume":"76","author":"P Kumar","year":"2001","unstructured":"Kumar P, Radhakrishnan J, Chowdhary MA, Giampietro PF. Prevalence and patterns of presentation of genetic disorders in a pediatric emergency department. Mayo Clin Proc. 2001;76:777\u201383.","journal-title":"Mayo Clin Proc"},{"key":"714_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ajmg.1320210205","volume":"21","author":"T Costa","year":"1985","unstructured":"Costa T, Scriver CR, Childs B. The effect of Mendelian disease on human health: a measurement. Am J Med Genet. 1985;21:231\u201342.","journal-title":"Am J Med Genet"},{"key":"714_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ajhg.2015.06.009","volume":"97","author":"JX Chong","year":"2015","unstructured":"Chong JX, Buckingham KJ, Jhangiani SN, Boehm C, Sobreira N, Smith JD, Harrell TM, McMillin MJ, Wiszniewski W, Gambin T, et al. The genetic basis of Mendelian phenotypes: discoveries, challenges, and opportunities. Am J Hum Genet. 2015;97:199\u2013215.","journal-title":"Am J Hum Genet"},{"key":"714_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajhg.2016.06.001","volume":"99","author":"LM Amendola","year":"2016","unstructured":"Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, Berg JS, Biswas S, Bowling KM, Conlin LK, et al. Performance of ACMG-AMP variant-interpretation guidelines among nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet. 2016;99:247.","journal-title":"Am J Hum Genet"},{"key":"714_CR6","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u20137.","journal-title":"Nucleic Acids Res"},{"key":"714_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/0883073814545884","volume":"30","author":"MM Segal","year":"2015","unstructured":"Segal MM, Abdellateef M, El-Hattab AW, Hilbush BS, De La Vega FM, Tromp G, Williams MS, Betensky RA, Gleeson J. Clinical pertinence metric enables hypothesis-independent genome-phenome analysis for neurologic diagnosis. J Child Neurol. 2015;30:881\u20138.","journal-title":"J Child Neurol"},{"key":"714_CR8","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","volume":"369","author":"Y Yang","year":"2013","unstructured":"Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502\u201311.","journal-title":"N Engl J Med"},{"key":"714_CR9","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s00429-016-1342-6","volume":"222","author":"V Kyriakopoulou","year":"2017","unstructured":"Kyriakopoulou V, Vatansever D, Davidson A, Patkee P, Elkommos S, Chew A, Martinez-Biarge M, Hagberg B, Damodaram M, Allsop J, et al. Normative biometry of the fetal brain using magnetic resonance imaging. Brain Struct Funct. 2017;222:2295\u2013307.","journal-title":"Brain Struct Funct"},{"key":"714_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12311-015-0699-z","volume":"15","author":"A Poretti","year":"2016","unstructured":"Poretti A, Boltshauser E, Huisman T. Pre- and postnatal neuroimaging of congenital cerebellar abnormalities. Cerebellum. 2016;15:5\u20139.","journal-title":"Cerebellum"},{"key":"714_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1126\/science.aar6731","volume":"362","author":"HC Martin","year":"2018","unstructured":"Martin HC, Jones WD, McIntyre R, Sanchez-Andrade G, Sanderson M, Stephenson JD, Jones CP, Handsaker J, Gallone G, Bruntraeger M, et al. Quantifying the contribution of recessive coding variation to developmental disorders. Science. 2018;362:1161\u20134.","journal-title":"Science"},{"key":"714_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1126\/science.1247363","volume":"343","author":"G Novarino","year":"2014","unstructured":"Novarino G, Fenstermaker AG, Zaki MS, Hofree M, Silhavy JL, Heiberg AD, Abdellateef M, Rosti B, Scott E, Mansour L, et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science. 2014;343:506\u201311.","journal-title":"Science"},{"key":"714_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"714_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/gim.2017.192","volume":"20","author":"RV Sanghvi","year":"2018","unstructured":"Sanghvi RV, Buhay CJ, Powell BC, Tsai EA, Dorschner MO, Hong CS, Lebo MS, Sasson A, Hanna DS, McGee S, et al. Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers. Genet Med. 2018;20:855\u201366.","journal-title":"Genet Med"},{"key":"714_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/gim.2017.162","volume":"20","author":"S Nambot","year":"2018","unstructured":"Nambot S, Thevenon J, Kuentz P, Duffourd Y, Tisserant E, Bruel AL, Mosca-Boidron AL, Masurel-Paulet A, Lehalle D, Jean-Marcais N, et al. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and\/or intellectual disability: substantial interest of prospective annual reanalysis. Genet Med. 2018;20:645\u201354.","journal-title":"Genet Med"},{"key":"714_CR16","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1056\/NEJMoa1515792","volume":"374","author":"M Tarailo-Graovac","year":"2016","unstructured":"Tarailo-Graovac M, Shyr C, Ross CJ, Horvath GA, Salvarinova R, Ye XC, Zhang LH, Bhavsar AP, Lee JJ, Drogemoller BI, et al. Exome sequencing and the Management of Neurometabolic Disorders. N Engl J Med. 2016;374:2246\u201355.","journal-title":"N Engl J Med"},{"key":"714_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/GIM.0b013e3182088158","volume":"13","author":"EA Worthey","year":"2011","unstructured":"Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, Serpe JM, Dasu T, Tschannen MR, Veith RL, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13:255\u201362.","journal-title":"Genet Med"},{"key":"714_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ng.3304","volume":"47","author":"JC Taylor","year":"2015","unstructured":"Taylor JC, Martin HC, Lise S, Broxholme J, Cazier JB, Rimmer A, Kanapin A, Lunter G, Fiddy S, Allan C, et al. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat Genet. 2015;47:717\u201326.","journal-title":"Nat Genet"},{"key":"714_CR19","doi-asserted-by":"publisher","first-page":"eaal5209","DOI":"10.1126\/scitranslmed.aal5209","volume":"9","author":"BB Cummings","year":"2017","unstructured":"Cummings BB, Marshall JL, Tukiainen T, Lek M, Donkervoort S, Foley AR, Bolduc V, Waddell LB, Sandaradura SA, O'Grady GL, et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med. 2017;9:eaal5209.","journal-title":"Sci Transl Med"},{"key":"714_CR20","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.14601","volume":"312","author":"Y Yang","year":"2014","unstructured":"Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312:1870\u20139.","journal-title":"JAMA"},{"key":"714_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/pd.4916","volume":"36","author":"E Quinlan-Jones","year":"2016","unstructured":"Quinlan-Jones E, Kilby MD, Greenfield S, Parker M, McMullan D, Hurles ME, Hillman SC. Prenatal whole exome sequencing: the views of clinicians, scientists, genetic counsellors and patient representatives. Prenat Diagn. 2016;36:935\u201341.","journal-title":"Prenat Diagn"},{"key":"714_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/uog.14636","volume":"45","author":"R Akolekar","year":"2015","unstructured":"Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:16\u201326.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"714_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ogc.2017.02.004","volume":"44","author":"LM Carlson","year":"2017","unstructured":"Carlson LM, Vora NL. Prenatal diagnosis: screening and diagnostic tools. Obstet Gynecol Clin N Am. 2017;44:245\u201356.","journal-title":"Obstet Gynecol Clin N Am"},{"key":"714_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/gm475","volume":"5","author":"N Van der Aa","year":"2013","unstructured":"Van der Aa N, Zamani Esteki M, Vermeesch JR, Voet T. Preimplantation genetic diagnosis guided by single-cell genomics. Genome Med. 2013;5:71.","journal-title":"Genome Med"},{"key":"714_CR25","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.fertnstert.2007.07.1337","volume":"90","author":"CM DeUgarte","year":"2008","unstructured":"DeUgarte CM, Li M, Surrey M, Danzer H, Hill D, DeCherney AH. Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis. Fertil Steril. 2008;90:1049\u201354.","journal-title":"Fertil Steril"},{"key":"714_CR26","first-page":"14","volume":"27","author":"H Daum","year":"2018","unstructured":"Daum H, Meiner V, Elpeleg O, Harel T, Collaborating A. Fetal exome sequencing: yield and limitations in a single tertiary center. Ultrasound Obstet Gynecol. 2018;27:14.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"714_CR27","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jnr.23905","volume":"94","author":"CA Saavedra-Matiz","year":"2016","unstructured":"Saavedra-Matiz CA, Luzi P, Nichols M, Orsini JJ, Caggana M, Wenger DA. Expression of individual mutations and haplotypes in the galactocerebrosidase gene identified by the newborn screening program in New York state and in confirmed cases of Krabbe's disease. J Neurosci Res. 2016;94:1076\u201383.","journal-title":"J Neurosci Res"},{"key":"714_CR28","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ng.2745","volume":"45","author":"PR Sosnay","year":"2013","unstructured":"Sosnay PR, Siklosi KR, Van Goor F, Kaniecki K, Yu H, Sharma N, Ramalho AS, Amaral MD, Dorfman R, Zielenski J, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013;45:1160\u20137.","journal-title":"Nat Genet"},{"key":"714_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-0038-1636995","volume":"7","author":"G Costain","year":"2018","unstructured":"Costain G, Inbar-Feigenberg M, Saleh M, Yaniv-Salem S, Ryan G, Morgen E, Goh ES, Nishimura G, Chitayat D. Challenges in diagnosing rare genetic causes of common in utero presentations: report of two patients with Mucolipidosis type II (I-cell disease). J Pediatr Genet. 2018;7:134\u20137.","journal-title":"J Pediatr Genet"},{"key":"714_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1516767","volume":"376","author":"JE Posey","year":"2017","unstructured":"Posey JE, Harel T, Liu P, Rosenfeld JA, James RA, Coban Akdemir ZH, Walkiewicz M, Bi W, Xiao R, Ding Y, et al. Resolution of disease phenotypes resulting from multilocus genomic variation. N Engl J Med. 2017;376:21\u201331.","journal-title":"N Engl J Med"},{"key":"714_CR31","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/brain\/aww221","volume":"139","author":"ES Reid","year":"2016","unstructured":"Reid ES, Papandreou A, Drury S, Boustred C, Yue WW, Wedatilake Y, Beesley C, Jacques TS, Anderson G, Abulhoul L, et al. Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. Brain. 2016;139:2844\u201354.","journal-title":"Brain"},{"key":"714_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/gim.2013.83","volume":"16","author":"MA Umbarger","year":"2014","unstructured":"Umbarger MA, Kennedy CJ, Saunders P, Breton B, Chennagiri N, Emhoff J, Greger V, Hallam S, Maganzini D, Micale C, et al. Next-generation carrier screening. Genet Med. 2014;16:132\u201340.","journal-title":"Genet Med"},{"key":"714_CR33","doi-asserted-by":"publisher","first-page":"65ra64","DOI":"10.1126\/scitranslmed.3001756","volume":"3","author":"CJ Bell","year":"2011","unstructured":"Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med. 2011;3:65ra64.","journal-title":"Sci Transl Med"},{"issue":"Suppl 3","key":"714_CR34","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1007\/PL00014401","volume":"159","author":"MM Kaback","year":"2000","unstructured":"Kaback MM. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatr. 2000;159(Suppl 3):S192\u20135.","journal-title":"Eur J Pediatr"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-020-0714-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-020-0714-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-020-0714-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T23:21:57Z","timestamp":1620861717000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-020-0714-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1186\/s12920-020-0714-1","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"5 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of California San Diego Human Research Protection Program (HRPP) IRB approved recruitment of subjects for NGS and return of research results to the referring physician and family under protocol #140028 entitled \u201cThe Genetics of Childhood Neurological Diseases\u201d with Dr. Gleeson as PI. All subjects or their parents or legal guardians signed a consent in their fluent language, and additionally an assent was signed by mentally capable underaged individuals in the form of a childhood assent if between the ages of 7\u201312, and an adolescent assent if between the ages of 13\u201316\u2009years of age. The study was submitted to and approved by the Egyptian National Research Centre Medical Research Ethical Committee (MREC) serving as the local ethics committee in Egypt. The Egyptian National Research Centre Medical Research Ethical Committee (MREC) IRB approved the study for confirmation of research results, fetal genotyping and genetic counseling for families from the Clinical Genetics Department with Dr. Zaki as PI. The Egyptian National Research Centre Medical Research Ethical Committee (MREC) IRB approved the study for the Department of Prenatal Diagnosis and Fetal Medicine with Dr. Gaber as PI for amniocentesis, genetic testing, and eTOP. The IRBs were independent from the investigators and sponsors, and were from the same institute and country in which the study took place. Appropriate ethical committee approval was included for both countries.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication of identifying images and other personal and clinical details of participants that compromise anonymity was documented in the consent form that was signed by all participants. Written consent for publication of identifying images or other personal or clinical details of participants under the age of 18 that compromise anonymity was documented in the consent form and signed by parents or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}